[3] Jackman H, Morris PW, Deddish PA, Skidgel RA, Erdos EG.
Inactivation of endothelin I by deamidase (lysosomal protective protein).
J Biol Chem 1992;267:2872-5.
[4] Kase R, Itoh K, Takiyama N, Oshima A, Sakuraba H, Suzuki Y.
Galactosialidosis: Simultaneous deficiency of esterase, carboxy-terminal
deamidase and acid carboxypeptidase activities. Biochem Biophys Res
Commun 1990;172:1175-9.
[5] Galjart NJ, Gillemans N, Harris A, et al. Expression of cDNA
encoding the human “protective protein” associated with lysosomal
β-galactosidase and neuramidase: Homology to yeast proteases. Cell
1988;54:755-64.
[6] Itoh K, Taiyama N, Kase R, et al. Purification and characterization of human lysosomal protective protein expressed in stably transformed Chinese hamster ovary cells. J Biol Chem 1993;268:1180-6.
[7] Satake A, Itoh K, Shimoto M, Saido T, Sakuraba H, Suzuki Y.
Distribution of lysosomal protective protein in human tissues. Biochem
Biophys Res Commun 1994;205:38-43.
[8] Shimoto M, Fukuhara Y, Itoh K, Oshima A, Sakuraba H, Suzuki
Y. Protective protein gene mutations in galactosialidosis. J Clin Invest
1993;91:2393-8.
[9] Takano T, Shimmoto M, Fukuhara Y, et al. Galactosialidosis:
Clinical and molecular analysis of 19 Japanese patients. Brain Dysfunct
1991;4:271-80.
[10] Oyanagi K, Ohama E, Miyashita K, et al. Galactosialidosis:
Neuropathological findings in a case of the late infantile type. Acta
Neuropathol (Berl) 1991;82:331-9.
[11] Lerner RA, Green N, Alexander H, Liu F, Sutcliffe JG,
Shinnick TM. Chemically synthesized peptides predicted from the
nucleotide sequence of the hepatitis B virus genome elicit antibodies
reactive with the native envelope protein of Dane particles. Proc Natl
Acad Sci U S A 1981;78:3403-7.
[12] Potier M, Michaux L, Tranchmontagne J, Thauvette E. Struc-
